Return to work after myocardial infarction: a retrospective study

Małgorzata Waszkowska1, Wiesław Szymczak

  • 1Department of Work Psychology, Nofer Institute of Occupational Medicine, Łódź, Poland. waszko@imp.lodz.pl

Insights

Workers returning to work after myocardial infarction often have better health and quality of life. Mental health assessment is crucial for determining work ability post-cardiac incident.

Area of Science:

  • Cardiology
  • Occupational Health
  • Psychology

Background:

  • Myocardial infarction (MI) significantly impacts a worker's ability to continue occupational activity.
  • Understanding factors influencing return to work after MI is vital for rehabilitation and workforce participation.

Purpose of the Study:

  • To assess occupational functioning in workers post-MI.
  • To identify health-related determinants for continuing occupational activity after MI.

Main Methods:

  • Retrospective study of 183 male workers (aged 39-65) post-MI.
  • Evaluated mental health, quality of life, and occupational functioning using NHP, Beck Depression Inventory, STAI, WAI, and a custom questionnaire.

Main Results:

  • Workers who returned to work were younger, more educated, and reported better self-rated health and quality of life.
  • Readaptation to work varied; maladapted individuals experienced depression, anxiety, and reduced work ability.

Conclusions:

  • Current work ability assessments post-MI, focusing only on physical health, are insufficient.
  • Mental health assessment should supplement physical evaluation for work capacity.
  • Employers should adapt working conditions to support workers post-MI.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...